| DRLYX | GRSRX | DRLYX / GRSRX | |
| Total Expense Ratio | 1.05 | 1.34 | 78% |
| Annual Report Gross Expense Ratio | 1.08 | 1.34 | 81% |
| Fund Existence | 13 years | 11 years | - |
| Gain YTD | 3.169 | 2.504 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 311M | 2.05B | 15% |
| Annual Yield % from dividends | 3.00 | 2.81 | 107% |
| Returns for 1 year | 11.60 | 11.15 | 104% |
| Returns for 3 years | 17.79 | 12.88 | 138% |
| Returns for 5 years | 11.64 | 16.35 | 71% |
| Returns for 10 years | 35.45 | 56.03 | 63% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OANWX | 27.11 | -0.24 | -0.88% |
| Oakmark Global Select Institutional | |||
| ECTGX | 116.99 | -1.29 | -1.09% |
| Eaton Vance Tx-Mgd Growth 1.1 C | |||
| MINVX | 29.13 | -0.37 | -1.25% |
| Madison Large Cap Y | |||
| ICTTX | 14.23 | -0.19 | -1.32% |
| ICON Health and Information Tech Inv | |||
| JGTTX | 37.49 | -0.62 | -1.63% |
| JPMorgan Growth Advantage R3 | |||